Targeting One develops in-vitro diagnostic products utilizing digital PCR technology for precise nucleic acid quantification. Their solutions enable accurate diagnosis and monitoring of various diseases, including cancer and viral infections, addressing the need for reliable and sensitive testing methods in clinical settings.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional PCR methods often lack the sensitivity and precision required for accurate quantification of nucleic acids, particularly in applications such as early disease detection, minimal residual disease monitoring, and precise viral load assessment. This limitation can lead to inaccurate diagnoses, delayed treatment decisions, and suboptimal patient outcomes.
Solution
Targeting One develops and manufactures digital PCR (dPCR) platforms and assays that enable highly sensitive and precise nucleic acid quantification for in-vitro diagnostics. Their dPCR technology partitions samples into thousands of individual reactions, allowing for absolute quantification of target molecules without the need for standard curves. This approach enhances the accuracy and reliability of diagnostic testing, enabling earlier detection of diseases, more precise monitoring of treatment response, and improved patient management. Targeting One offers a range of dPCR systems and assays for various applications, including cancer diagnostics, infectious disease detection, and liquid biopsy analysis.
Target Audience
Targeting One's products are designed for clinical laboratories, hospitals, research institutions, and diagnostic companies that require precise and sensitive nucleic acid quantification for diagnostic and research purposes.
Features
- Microdroplet dPCR technology for absolute quantification of nucleic acids
- Automated systems for streamlined workflow and high throughput
- Multiplexing capabilities for simultaneous detection of multiple targets
- Assays for a wide range of applications, including oncology, virology, and genetic testing
- High sensitivity and specificity for accurate detection of low-abundance targets
- User-friendly software for data analysis and reporting
- Compliant with relevant regulatory standards for in-vitro diagnostics